Frederiksberg, Denmark

Ernst Meinjohanns

This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Dupont Nutrition Biosciences Aps. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernst Meinjohanns. Retrieved from https://idiyas.com/inventor/ernst-meinjohanns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Ernst Meinjohanns: Pioneering Innovations in Frederiksberg C, DK

Introduction: Ernst Meinjohanns is a distinguished inventor based in Frederiksberg C, Denmark, known for his groundbreaking contributions to various technological fields.

Latest Patents: Meinjohanns holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to driving innovation forward.

Career Highlights: With a career spanning over two decades, Ernst Meinjohanns has worked with leading research institutions and multinational corporations to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Meinjohanns has collaborated with top universities and research institutions worldwide, fostering a culture of knowledge exchange and pushing the boundaries of what is possible in the realm of technology and engineering.

Conclusion: Ernst Meinjohanns continues to be a driving force in the world of innovation, with his relentless pursuit of excellence and passion for creating a better future through his inventive spirit.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…